STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Celltrion today announced the U.S. launch of STEQEYMA��(ustekinumab-stba), a biosimilar to STELARA� (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

On a military base in El Paso, Texas, masked men in combat fatigues paraded a group of young Venezuelan immigrants, their hands cuffed and their ankles shackled, in front of the cameras, before ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically ...

The Plano pharmacist billed federal and private payers for hundreds of millions while paying out millions in kickbacks to ...

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...

The Trump administration is rolling out a new strategy ... the plan prioritizes enhanced biosecurity measures and medication to control the spread of the virus. Vaccine Approval: Zoetis received ...